XU Daqiang, ZHAO Jiali, SUN Huanjian, YANG Huilin. Design and preclinical study of a fracture reduction and fixation system[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 63-67. DOI: 10.7619/jcmp.20241626
Citation: XU Daqiang, ZHAO Jiali, SUN Huanjian, YANG Huilin. Design and preclinical study of a fracture reduction and fixation system[J]. Journal of Clinical Medicine in Practice, 2024, 28(11): 63-67. DOI: 10.7619/jcmp.20241626

Design and preclinical study of a fracture reduction and fixation system

More Information
  • Received Date: April 21, 2024
  • Revised Date: May 23, 2024
  • Available Online: June 17, 2024
  • Objective 

    To investigate the safety, efficacy, and clinical value of a fracture reduction and fixation system.

    Methods 

    The design and application of components [Kirschner wire (K-wire) limiter and K-wire guiding locking device] of the fracture reduction and fixation system were described. Six surgeons implanted K-wires into synthetic bones using the K-wire limiter or by perception respectively, and the length of K-wire protrusion was assessed. K-wire guiding locking device combined with locking plates and two 1.5 mm K-wires, two 1.5 mm K-wires, as well as two 2.0 mm K-wires were used to fix a fracture model constructed by synthetic bones, and the torque at failure was measured.

    Results 

    The K-wire limiter reduced the length of K-wire protrusion(P < 0.001). The failure torque of fractures fixed by K-wire guiding locking device with locking plates and two 1.5 mm K-wires was larger than those fixed with two 1.5 mm K-wires and two 2.0 mm K-wires(P < 0.05).

    Conclusion 

    The fracture reduction and fixation system offers a new technique for reducing and reconstructing fractures, assessing and optimizing the position of locking plate screws, as well as protecting the blood supply of fractures.

  • [1]
    HELFET D L, HAAS N P, SCHATZKER J, et al. AO philosophy and principles of fracture management-its evolution and evaluation[J]. J Bone Joint Surg Am, 2003, 85(6): 1156-1160. doi: 10.2106/00004623-200306000-00029
    [2]
    曾炳芳, 罗从风. 重视骨折并发症的处理[J]. 中华创伤骨科杂志, 2006(7): 601-602. doi: 10.3760/cma.j.issn.1671-7600.2006.07.001
    [3]
    RICHARD E B, CHRISTOPHER G M, THEERACHAI A, 等. 骨折治疗的AO原则(第3版)[M]. 上海: 上海科学技术出版社, 2019: 114-116.
    [4]
    刘波, 曹光华, 张文玺, 等. 3D打印技术在腓骨头上入路治疗复杂胫骨平台后外侧骨折中的临床应用[J]. 实用临床医药杂志, 2024, 28(5): 17-20, 58. doi: 10.7619/jcmp.20232950
    [5]
    OTT N, HACKL M, PRESCHER A, et al. The effect of long calcar screws on the primary stability of 3-part, varus impacted proximal humeral fractures compared to short calcar screws: a real fracture simulation study[J]. Arch Orthop Trauma Surg, 2023, 143(5): 2485-2491.
    [6]
    BEL J C. Pitfalls and limits of locking plates[J]. Orthop Traumatol Surg Res, 2019, 105(1S): S103-S109.
    [7]
    杨惠光. 锁定钢板内固定治疗肱骨近端骨折[J]. 实用临床医药杂志, 2007, 11(11): 49. doi: 10.3969/j.issn.1672-2353.2007.11.016
    [8]
    杨惠林, 徐达强, 施勤. 一种混合锁定接骨板系统及配套起子, CN 217186385U[P]. 2022-08-16. https://zhuanli.tianyancha.com/a07351bb7d43082e5b400b224703e914.
    [9]
    徐达强. 一种导向锁紧装置及其骨折固定系统: CN219835670U[P]. 2023-10-17. https://zhuanli.tianyancha.com/8b45b75d94482310c10119df200774f4.
    [10]
    王岳娜. 手术物品清点的综合管理措施[J]. 中华现代护理杂志, 2013, 48(33): 4161-4163. doi: 10.3760/cma.j.issn.1674-2907.2013.33.039
    [11]
    FRANCISCO D P(编著), 谭军(主译). 桡骨远端骨折手术图谱[M]. 上海: 上海科学技术出版社, 2020: 25.
  • Related Articles

    [1]LI Jinpei, WANG Yonghuai, LI Guangyuan, MA Chunyan, YANG Jun. Research progress on risk factors of coronary slow flow[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 115-118. DOI: 10.7619/jcmp.20220353
    [2]CHEN Haiyan, FU Xiaodan, ZHANG Qiuju. Relationships of indicators such as level of plasma lipoprotein-associated phospholipase A2 with effect of extracorporeal counterpulsation therapy in high-risk patients with coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 63-67. DOI: 10.7619/jcmp.20214222
    [3]GONG Xiaoyong, HU Xiaowei, HE Fei, HU Jianping. Correlations between serum levels of brain natriuretic peptide, hypersensitive C-reactive protein as well as creatine kinase isoenzyme and prognosis of patients after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 72-76. DOI: 10.7619/jcmp.20211053
    [4]LI Jiancheng, XU Gangzheng. Value of hypersensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients with interventional therapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 34-36. DOI: 10.7619/jcmp.202018009
    [5]WANG Dong. Effect of maixuekang capsule combined with percutaneous coronary intervention on platelet aggregation rate and high sensitivity C-reactive protein in patients with acute coronarysyndrome[J]. Journal of Clinical Medicine in Practice, 2018, (5): 42-44. DOI: 10.7619/jcmp.201805013
    [6]WANG Yanhua. Clinical significance of changes in levels of high sensitive C-reactive protein and cardiac troponin-T in patients with coronary heart disease after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2015, (7): 29-31. DOI: 10.7619/jcmp.201507007
    [7]WANG Junjun, YU Chunjuan, DING Qilong, XING Ting. Correlation between serum high sensitivity C-reactive protein and atherosclerosis in patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (5): 5-7. DOI: 10.7619/jcmp.201505002
    [8]CAI Guodong, GU Yang, LIU Shengshan, ZHU Hairong. Change and significance of plasma lipoprotein-associated phospholipase A2 and Lipoprotein(a)levels in atherosclerotic cerebral infraction[J]. Journal of Clinical Medicine in Practice, 2014, (16): 18-21. DOI: 10.7619/jcmp.201416005
    [9]Application of high sensitivity C-reactive protein and pressure wire in dealing with critical lesion during coronary artery intervention[J]. Journal of Clinical Medicine in Practice, 2013, (21): 12-15. DOI: 10.7619/jcmp.201321004
    [10]ZHANG Ying, QIN Shu, ZHANG Dongyin, WANG Kechun. Relationship between high-sensitivity C-reactive protein and the severity and prognosis of coronary atherosclerosis of coronary heart disease[J]. Journal of Clinical Medicine in Practice, 2012, (23): 45-48.
  • Cited by

    Periodical cited type(11)

    1. 刘亚男,房志琴,郭健宏,王亚玲. 冠状动脉慢血流患者血清Lp-PLA_2、NLR水平变化及临床意义. 广东医学. 2024(06): 717-722 .
    2. 朱雅男,张志强,徐继方,朱云霞,安梦秋. 冠状动脉慢血流的相关血清学分析. 心肺血管病杂志. 2023(01): 23-26 .
    3. 孙晓慧,贺静,王瑶,白蓉,薛晓珍,杨莉,乌宇亮. 血清脂蛋白相关磷脂酶A2水平与冠状动脉病变程度及慢血流的相关性分析. 临床医学研究与实践. 2023(26): 9-12 .
    4. 师志芳,贾营,张秀敬,谭化,王爱民,赵洁. 血清血小板活化因子和脂蛋白相关磷脂酶AA2对冠状动脉慢血流现象的预测价值分析. 中国心血管病研究. 2023(12): 1080-1085 .
    5. 梁万添,唐良秋,陈锦峰,庞军刚,周婉明,陈伟强,陈姣. 小檗碱对急性心肌梗死经皮冠状动脉介入术后冠状动脉不稳定斑块的治疗作用. 中国医药. 2021(01): 28-32 .
    6. 刘玲玲,韩磊. 冠状动脉慢血流与超敏CRP及左室舒张功能的相关性研究. 中国医药指南. 2021(22): 11-13 .
    7. 朱宝华,孙岩. 冠状动脉疾病差异基因富集和加权基因共表达网络分析. 实用临床医药杂志. 2021(17): 15-21 . 本站查看
    8. 陶金松,李健,徐霞,陆翊超,李伟章. 冠心病患者介入术中并发冠状动脉慢血流的影响因素. 现代医学与健康研究电子杂志. 2021(19): 93-95 .
    9. 陆爱民,童有福,赵艳. 利伐沙班对冠状动脉慢血流患者凝血功能及C反应蛋白的影响. 医学综述. 2021(21): 4354-4359 .
    10. 孙涛,张艳丽,侯梅凤,姚成俊,潘闽. 血清脂蛋白(a)[Lp(a)]、血清超敏C反应蛋白(hs-CRP)与冠状动脉慢血流之间的相关性. 系统医学. 2021(22): 32-36 .
    11. 陈艳俏,程伟,张成英,陈少军,马友合,孙久林. 保元汤合桂枝茯苓丸治疗冠状动脉慢血流临床观察. 中国中医药现代远程教育. 2020(19): 70-73 .

    Other cited types(0)

Catalog

    Article views (104) PDF downloads (15) Cited by(11)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return